Tandem Diabetes Care (TNDM) Return on Invested Capital (2024 - 2025)
Tandem Diabetes Care's (TNDM) quarterly Return on Invested Capital came in at 0.03% in Q4 2025, down 2.0% YoY from 0.03% in Q4 2024, and down 63.79% on a QoQ basis from 0.02% in Q3 2025.
Tandem Diabetes Care (TNDM) Return on Invested Capital (2024 - 2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has 2 years of Return on Invested Capital data on file, last reported at 0.03% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 0.04% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.02% |